| Date | Source | Headline | |
|---|---|---|---|
| 31st Dec 2025 | 1:24 pm | RNS-R | Novo Nordisk A/S: China's Supreme People's Court delivers a positive ruling on the semaglutide compound patent |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.